Scarica l'app Stockscreener
54.15
5.56%
2.85
Dopo l'orario di chiusura:
54.13
-0.02
-0.04%
Precedente Chiudi:
$51.30
Aprire:
$51.09
Volume 24 ore:
63,863
Relative Volume:
0.46
Capitalizzazione di mercato:
$598.88M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+1.37%
1M Prestazione:
+39.27%
6M Prestazione:
+187.27%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$49.81
$54.15
Intervallo di 1 settimana:
$49.13
$57.19
Portata 52W:
$11.17
$57.19
Palvella Therapeutics Inc Stock (PVLA) Company Profile
Nome
Palvella Therapeutics Inc
Settore
Industria
Telefono
(484) 253-1461
Indirizzo
125 STRAFFORD AVE, WAYNE
Confronta PVLA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PVLA
Palvella Therapeutics Inc
|
54.15 | 567.36M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Palvella Therapeutics Inc Stock (PVLA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-06 | Iniziato | Raymond James | Outperform |
| 2025-07-21 | Iniziato | Truist | Buy |
| 2025-04-09 | Iniziato | Chardan Capital Markets | Buy |
| 2025-03-26 | Iniziato | Stifel | Buy |
| 2025-03-07 | Iniziato | Scotiabank | Sector Outperform |
| 2025-02-20 | Iniziato | Canaccord Genuity | Buy |
| 2025-02-05 | Iniziato | TD Cowen | Buy |
| 2024-12-26 | Iniziato | H.C. Wainwright | Buy |
| 2024-12-18 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-03-13 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-07-30 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2019-05-14 | Iniziato | Robert W. Baird | Outperform |
| 2018-03-19 | Iniziato | Evercore ISI | Outperform |
| 2018-03-19 | Iniziato | Jefferies | Buy |
| 2018-01-16 | Reiterato | H.C. Wainwright | Buy |
| 2017-05-30 | Iniziato | Rodman & Renshaw | Buy |
| 2016-08-05 | Ripresa | ROTH Capital | Buy |
| 2015-08-12 | Iniziato | JMP Securities | Mkt Outperform |
| 2015-07-27 | Iniziato | Oppenheimer | Outperform |
| 2015-07-22 | Iniziato | ROTH Capital | Buy |
Mostra tutto
Palvella Therapeutics Inc Borsa (PVLA) Ultime notizie
Palvella Therapeutics Inc.’s volatility index tracking explainedPortfolio Performance Summary & Real-Time Volume Spike Alerts - Newser
Is Palvella Therapeutics Inc. stock poised for growthJuly 2025 Recap & Advanced Technical Signal Analysis - Newser
Using portfolio simulators with Palvella Therapeutics Inc. includedWeekly Earnings Recap & Proven Capital Preservation Tips - Newser
Candlestick Signal Suggests Reversal in Palvella Therapeutics Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Is Palvella Therapeutics Inc. showing signs of accumulationQuarterly Portfolio Report & Expert Approved Momentum Trade Ideas - Newser
What high frequency data says about Palvella Therapeutics Inc.Options Play & Real-Time Market Sentiment Alerts - Newser
News impact scoring models applied to Palvella Therapeutics IncBuy Signal & Accurate Entry and Exit Point Alerts - Newser
News impact scoring models applied to Palvella Therapeutics Inc.Earnings Overview Report & Safe Investment Capital Preservation Plans - Newser
Using RSI to spot recovery in Palvella Therapeutics Inc.Exit Point & Risk Adjusted Swing Trade Ideas - Newser
Using data models to predict Palvella Therapeutics Inc. stock movementRate Cut & AI Enhanced Trading Signals - Newser
Published on: 2025-08-31 12:23:33 - Newser
Applying Elliott Wave Theory to Palvella Therapeutics Inc.Global Markets & Long-Term Safe Investment Plans - Newser
Is Palvella Therapeutics Inc. stock entering bullish territory2025 EndofYear Setup & High Return Stock Watch Alerts - Newser
Quantitative breakdown of Palvella Therapeutics Inc. recent moveWeekly Gains Summary & Detailed Earnings Play Strategies - Newser
Palvella Therapeutics Inc. Shows Risk Reward Favoring Upside2025 Biggest Moves & Safe Capital Growth Tips - beatles.ru
What institutional flow reveals about Palvella Therapeutics Inc.Volume Spike & Free Risk Controlled Daily Trade Plans - Newser
Will Palvella Therapeutics Inc. stock recover after recent dropRecession Risk & Community Consensus Picks - Newser
Recovery Signals Appearing in Palvella Therapeutics Inc. Charts getLinesFromResByArray error: size == 0 - thegnnews.com
Will Palvella Therapeutics Inc. benefit from macro trendsAnalyst Upgrade & Scalable Portfolio Growth Methods - Newser
Ranking Palvella Therapeutics Inc. among high performing stocks via toolsWeekly Trade Analysis & AI Enhanced Market Trend Forecasts - Newser
How hedge fund analytics apply to Palvella Therapeutics Inc. stockEarnings Miss & Breakout Confirmation Alerts - Newser
Palvella Therapeutics Inc Azioni (PVLA) Dati Finanziari
Non sono disponibili dati finanziari per Palvella Therapeutics Inc (PVLA). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.96%
1.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):